IMPLANTABLE MEDICAL DEVICE HAVING ISOLATED MULTI-CELL POWER SOURCES
    1.
    发明申请
    IMPLANTABLE MEDICAL DEVICE HAVING ISOLATED MULTI-CELL POWER SOURCES 有权
    具有隔离多个电源的可植入医疗设备

    公开(公告)号:US20160067512A1

    公开(公告)日:2016-03-10

    申请号:US14844697

    申请日:2015-09-03

    Abstract: Implantable medical device systems of the present disclosure may include a subcutaneous implantable cardioverter defibrillator (SICD) that is powered by a multi-cell power source that is connected to a transformer and power conversion circuitry to charge one or more relatively small, but powerful, high voltage capacitors to provide a relatively high discharge voltage. The SICD includes electrical isolation for the multi-cell power source to protect against cross-charging between the cells during the operational lifetime of the SICD.

    Abstract translation: 本公开的可植入医疗装置系统可以包括皮下植入式心律转复除颤器(SICD),该皮下植入式心律转复除颤器由多单元电源供电,所述多单元电源连接到变压器和电力转换电路,以对一个或多个相对小但强大的高 电压电容器提供相对较高的放电电压。 SICD包括多单元电源的电隔离,以防止在SICD的使用寿命期间电池之间的交叉充电。

    Monitoring multi-cell power source of an implantable medical device

    公开(公告)号:US09861828B2

    公开(公告)日:2018-01-09

    申请号:US14695826

    申请日:2015-04-24

    CPC classification number: A61N1/3975 A61N1/3925 A61N1/3956

    Abstract: An implantable medical device includes a low-power circuit and a multi-cell power source. The cells of the power source are coupled in a parallel configuration. The implantable medical device includes both a low power circuit and a high power circuit that are coupled between the first and second cells. An isolation circuit is coupled to the first cell and the second cell in a safe parallel orientation and the first and second cells are configured in a first configuration to deliver energy to the low power circuit segment and in a second configuration that is different from the first configuration to deliver energy to the high power circuit segment. A monitoring circuit is coupled to the power source and operable to evaluate the first cell and the second cell to detect a fault condition associated with at least one of the first and second cells.

Patent Agency Ranking